Back to search

Article

Safety and Efficacy of Nirmatrelvir/Ritonavir in Advanced Kidney Disease

2023-07-05

Abstract excerpt

Background: Nirmatrelvir/ritonavir is mainly used in patients with normal renal function or with only mild renal impairment (eGFR ³ 30 ml/min per 1.73m2). There is limited data regarding its use in advanced kidney disease. We performed a retrospective territory-wide cohort study evaluating the safety and efficacy of nirmatrelvir/ritonavir when compared with molnupiravir.Nirmatrelvir/ritonavir is mainly used in pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e5653b4-6009-566d-8c92-54d612344037
DOI
10.2139/ssrn.4496138
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety and Efficacy of Nirmatrelvir/Ritonavir in Advanced Kidney DiseaseDOI 10.2139/ssrn.4496138
Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysisSemantic proximity
Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational studySemantic proximity
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational studySemantic proximity
Comparative study of COVID-19 infection in renal transplant recipients and non transplant recipientsSemantic proximity
Comparative Study of COVID-19 Infection in Renal Transplant Recipients and Non Transplant RecipientsSemantic proximity
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World DataSemantic proximity
Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patientsSemantic proximity
Clinical characteristics and outcomes in COVID-19 patients with chronic kidney disease in the SARS-CoV-2 Omicron wave: a case-control studySemantic proximity
Molnupiravir Compared to Nirmatrelvir/Ritonavir for COVID-19 in High-Risk Patients with Haematological Malignancy in Europe. A Matched-Paired Analysis from the Epicovideha RegistrySemantic proximity
Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients.Semantic proximity
Comparative study of COVID-19 infection in renal transplant recipients and non transplant recipientsSemantic proximity
Potential role of ACE2-related microRNAs in COVID-19-associated nephropathySemantic proximity
Select a neighboring publication to make it the new centre.